UCLA researchers in the Department of Bioengineering have developed a new technology that can perform robust single-cell isolation and droplet emulsification for assay.
Isolation of individual cells or biomarkers such as nucleic acids, protein, or exosomes is a critical step in assaying for disease state and diagnostics. Capturing cells and/or biomarkers from patient serum/sample itself is a challenging task, the ability to then isolate these captured populations into an assay ready format is equally challenging. These processes currently require manual low throughout-multistep procedures to obtain assay ready material.
UCLA researchers led by Prof. Dino Di Carlo have developed a single-step high throughput method to capture rare cell types and biomarkers and then subsequently form small volume droplets for downstream bio-assay. They demonstrated that they can isolate and capture rare cancer biomarkers from whole blood samples for in vitro analysis for diagnostic and treatment purposes using their technology.
Researchers have validated their device using whole blood samples to capture CTCs and assay for matrix metalloproteinase activity.
|United States Of America||Issued Patent||10717086||07/21/2020||2016-861|
cancer, CTCs, circulating tumor cells, circulating cancer cells, cancer biomarkers, biomarkers, biomarker capture, emulsification, droplet assay, droplet formation, sample encapsulation, sample isolation